Clopidogrel bisulfate - Daewoong Pharmaceutical
Alternative Names: DWC-202202Latest Information Update: 13 Oct 2025
At a glance
- Originator Daewoong Pharmaceutical
- Class 2 ring heterocyclic compounds; Antiplatelets; Chlorobenzenes; Esters; Pyridines; Small molecules; Thienopyridines
- Mechanism of Action Platelet ADP receptor antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atherosclerosis; Myocardial infarction; Peripheral arterial disorders; Stroke; Thromboembolism